跳至主要内容
临床试验/NCT00335101
NCT00335101撤回4 期

Renal Effects of Three Iodinated Contrast Media (CM) in Patients at Risk Undergoing Coronary Angiography

GE Healthcare3 个研究点 分布在 2 个国家开始时间: 2006年6月最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
撤回
发起方
GE Healthcare
试验地点
3
主要终点
Maximum peak increase in SCr from baseline up to day 3.

研究概览

简要总结

The study is to evaluate and compare the effects on kidney function of three iodinated contrast media (CM) in patients at risk of kidney damage evaluating serum creatinine (Scr) concentrations up to three days after CM administration.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Double

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects with a combination of DM (type I or II) and renal impairment (RI), defined as SCr ≥150 µmol/L (1.7 mg/dL) for men and ≥133 µmol/L (1.5 mg/dL) for women or creatinine clearance (CrCl) ≤50 mL/min calculated according to Cockroft-Gault formula, referred for coronary angiography with or without PCI.

排除标准

  • Concurrent administration of potentially nephroprotective or nephrotoxic drugs is not allowed. Subjects undergoing dialysis or kidney transplantation or with CrCl < 20 mL/min will not be included.

结局指标

主要结局

Maximum peak increase in SCr from baseline up to day 3.

Secondary endpoints:

Change in SCr from baseline to day 2 and to day 3

Number of subjects with contrast-induced nephropathy (CIN)

Primary endpoint:

Quality of diagnostic information

次要结局

  • Coronary Artery Disease (CAD)
  • Renal Impairment
  • Diabetes mellitus

研究者

发起方
GE Healthcare
申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验